Goueslard, Karine
Cottenet, Jonathan
Roussot, Adrien
Clesse, Christophe
Sagot, Paul
Quantin, Catherine http://orcid.org/0000-0001-5134-9411
Article History
Received: 1 August 2017
Accepted: 19 April 2018
First Online: 4 June 2018
Ethics approval and consent to participate
: This study was approved by the French Committee for data protection (registration number 1576793) and therefore was conducted in accordance with the Declaration of Helsinki. Written consent was not needed for this study. The hospital database was transmitted by the national agency for the management of hospitalization data (ATIH, registration number 2015–111111–47-33). Written consent was not needed for this study.
: Author PS received funding from the following commercial companies: Merck Serono, Finox Biotech, MSD France SAS, Teva Santé SAS, Allergan France, Gedeon Richter France, Effik S.A., Karl Storz Endoscopie France, GE Medical Systems SCS, Laboratoires Genevrier, H.A.C. Pharma, and Ipsen. Author PS confirms that none of this funding was used to support the research in this study. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.